ANTI-CD4 MONOCLONAL-ANTIBODY TREATMENT IN COMBINATION WITH TOTAL LYMPHOID IRRADIATION AND CYCLOSPORINE-A IN HAMSTER-TO-RAT CARDIAC TRANSPLANTATION

Citation
Da. Steinbruchel et al., ANTI-CD4 MONOCLONAL-ANTIBODY TREATMENT IN COMBINATION WITH TOTAL LYMPHOID IRRADIATION AND CYCLOSPORINE-A IN HAMSTER-TO-RAT CARDIAC TRANSPLANTATION, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 102(10), 1994, pp. 777-785
Citations number
35
Categorie Soggetti
Pathology,Microbiology,Immunology
ISSN journal
09034641
Volume
102
Issue
10
Year of publication
1994
Pages
777 - 785
Database
ISI
SICI code
0903-4641(1994)102:10<777:AMTICW>2.0.ZU;2-3
Abstract
Significantly prolonged graft survival (GS) of hamster hearts transpla nted heterotopically into rats can be achieved by different immunosupp ressive treatment strategies. The exact mechanism of graft rejection i s unclear, but it seems to be a primarily humoral, antibody-mediated t ype of rejection. The histopathology of long-term surviving grafts is controversial and the morphology of lymphoid tissue in spleens and lym ph nodes as the possible site of anti-donor antibody formation has not previously been investigated. This report demonstrates a significantl y prolonged GS in hamster-to-rat cardiac transplantation after combine d treatment with total lymphoid irradiation (TLI), cyclosporin A (CyA) and anti-CD4 monoclonal antibodies (MAb), where long-term GS (>100 da ys) could be achieved in a few animals. The histopathology of heart gr afts showed predominantly chronic vascular changes with endothelial pr oliferation, intimal thickening and vessel obliteration. No substantia l cellular reactivity in terms of mononuclear/lymphoid cell infiltrati on could be demonstrated in rejected grafts. Spleens and lymph nodes w ere characterized by a profound global reduction in lymphoid tissue af ter preoperative TLI. Although subsequent lymphoid regeneration was de pressed due to postoperative immunosuppression, a significant increase in IgM-positive plasma cells was observed, supporting evidence of an antibody-mediated mechanism of graft rejection. The role of CD4(+) cel ls is unclear, but anti-donor antibody formation might involve T-cell help.